{"id":339065,"date":"2026-11-04T13:50:36","date_gmt":"2026-11-04T08:20:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/nephrocare-health-serv-l-q2-results-fy27-pat-34-crore\/"},"modified":"2026-11-04T13:50:36","modified_gmt":"2026-11-04T08:20:36","slug":"nephrocare-health-serv-l-q2-results-fy27-pat-34-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nephrocare-health-serv-l-q2-results-fy27-pat-34-crore\/","title":{"rendered":"NEPHROCARE HEALTH SERV L Q2 Results FY27: PAT Rises 4.88% to Rs 33.53 Cr, Revenue Rs 303.40 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

NEPHROCARE HEALTH SERV L Q2 Results FY27 were declared on 3 November 2026 on a consolidated basis. Revenue came in at Rs 303.40 Cr, a QoQ growth of 7.68 percent from Rs 281.75 Cr. Net profit rose 4.88 percent to Rs 33.53 Cr from Rs 31.97 Cr. These quarterly results cover July to September 2026.<\/p>\n<\/div>\n

NEPHROCARE HEALTH SERV L (NEPHROPLUS) Q2 Results FY27 announced on 3 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 303.40 Cr and PAT of Rs 33.53 Cr. NEPHROCARE HEALTH SERV L Q2 Results FY27 set out the full picture for the quarter. The results date of 3 November 2026 and the consolidated results basis frame every figure below.<\/p>\n

This NEPHROCARE HEALTH SERV L Q2 Results results analysis covers the financial highlights, the business factors, the outlook and the risks, and it starts with the Financial Highlights table. Univest readers can use the Univest Screener to compare these figures with other listed companies.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n